REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
08/06/2026
Voltar para busca
Dado oficial do USPTO
LIGHTBIO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
LIGHTBIO
ST13
US500000079279617Classe
1, 5, 9, 40, 42
Pedido
79279617
Registro
6375045
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
36
Atualização mais recente
09/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9, 40, 42
Data de depósito
28/08/2019
Data de registro
08/06/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
08/06/2021
Última transação
09/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
Hampton TW12 2ER, GB
Examinador
LEVINE, HOWARD B
Unidade examinadora
M60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
LightBio Limited
Representantes
Rebecca Liebowitz Venable LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical preparationsenzymes and DNA for the preparation of nucleic acid for scientific research; chemicals for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; enzymes for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; DNA extracts and cassettes for scientific and research use; DNA extracts for use in scientific research in the field of agri-biotechnology and nanotechnology; nucleic acids comprising natural and unnatural nucleotides for use in laboratory nanotechnology applicationsdata storagedata retrieval and computing; nucleic acid analogues comprising synthetic backbones or a mixture of natural and synthetic backbones for use in laboratory nanotechnology applicationsdata storagedata retrieval and computing; composites of nucleic acids or nucleic acid analogues with organic and inorganic chemicals for use in laboratory nanotechnology applicationsdata storagedata retrieval and computing; nucleic acid analogues with organic and inorganic chemicals for laboratory use in labellingimaging and sensing applications; nucleic acid analogues with organic and inorganic chemicals for laboratory use in smart materials; two-dimensional and three-dimensional nucleic acid analogues with organic and inorganic chemicals for laboratory use in creating nanostructures and scaffolds; Nucleic acids comprising natural and unnatural nucleotides for laboratory use; nucleic acid analogues comprising synthetic backbones or a mixture of natural and synthetic backbones for laboratory use; composites of nucleic acids or nucleic acid analogues with organic and NAC inorganic chemicals for laboratory use; all the aforesaid goods for use in laboratory nanotechnology applicationsdata storagedata retrieval and computing
Classe 5
Vaccines; DNA based vaccines; DNA extractsnucleic acid sequences and chemical reagents for medical use; therapeutic DNAnucleic acid sequences and chemical reagents for medical and veterinary purposes; nucleic acids comprising natural and unnatural nucleotides for medical and veterinary purposes; nucleic acid analogues comprising synthetic backbones or a mixture of natural and synthetic backbones for medical and veterinary purposes; composites of nucleic acids or nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes; nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes in labelingimaging and sensing applications; nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes in smart materials; two-dimensional and three-dimensional nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes in creating nanostructures and scaffolds
Classe 9
Scientific apparatus and instrumentsapparatus for amplifying DNAreactors and bioreactors; apparatus for manufacturing DNAreactors and bioreactors; apparatus for processing DNAreactors and bioreactors; electronic componentsnucleic acid analogues in the nature of electric and power wiressemi-conductorstransistorsrectifiersdiodeslight emitting diodes and energy storage systems in the nature of devices for energy storagebatteriesfuel cells configured for energy storageelectrochemical devices configured for energy storageelectrolysers; electric and power wires comprised of nucleic acid composites (NACs) semi-conductorstransistorsrectifiersdiodeslight emitting diodes and energy storage systems in the nature of devices for energy storagebatteriesfuel cells configured for energy storageelectrochemical devices configured for energy storageelectrolyserseach comprised of nucleic acid composites (NACs); labelingimaging and sensing apparatus comprising of nucleic acid composites (NACs) for laboratory and research use; smart materials in the nature of DNA chipsDNA microarrayscomprised of nucleic acid composites; two-dimensional and three-dimensional nucleic acid composites (NACs) in the nature of DNA chipsDNA microarrays for creating nanostructures and scaffolds for use in electronic components and materialselectrical conductors; parts and fittings for all the aforesaid technology and parts and fittings for all the aforesaid goodselectrical cablesdisplay screenstransmitters
Classe 40
Chemical treatment of DNA to form DNA extracts; custom manufacture of therapeutic DNA by the manipulation of DNA into DNA extracts or cassettes
Classe 42
Scientific and technological services and research and design relating theretochemical and biological analysis and research services; DNA analysis services for scientific research purposes; scientific research and development into the creation of DNA extracts; scientific researchanalysisdesign and development relating to DNA based drugs and therapies; scientific research and development in the fields of gene therapygenetic diagnosticsagri-biotechnology and nanotechnologyall in the field of gene therapy; consultancy relating to the aforesaid services
Publicações
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
24/10/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
28/09/2021
FIMP
FINAL DISPOSITION PROCESSED
28/09/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/09/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
08/06/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/03/2021
PUBO
PUBLISHED FOR OPPOSITION
23/03/2021
GPNX
NOTIFICATION PROCESSED BY IB
21/03/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/03/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/03/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/03/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/02/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
16/02/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
16/02/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
16/02/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
16/02/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/02/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/02/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/02/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/01/2021
GNFR
FINAL REFUSAL E-MAILED
07/01/2021
CNFR
FINAL REFUSAL WRITTEN
07/01/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/12/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/12/2020
ALIE
ASSIGNED TO LIE
15/12/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/09/2020
RFNT
REFUSAL PROCESSED BY IB
10/04/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
25/03/2020
RFRR
REFUSAL PROCESSED BY MPU
25/03/2020
MAFR
APPLICATION FILING RECEIPT MAILED
06/03/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/03/2020
CNRT
NON-FINAL ACTION WRITTEN
03/03/2020
DOCK
ASSIGNED TO EXAMINER
02/03/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/03/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
27/02/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LIGHTBIO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.